Related Experiment Video
Updated: Jul 2, 2026

Quantifying Pulmonary Microvascular Density in Mice Across Lobules
Published on: January 3, 2025
Lung Pericytes: Molecular Mechanisms, Signaling Pathways, and Roles in Pulmonary Diseases
Stuti Agarwal1, Anuradha Bankar1, Vinicio A de Jesus Perez1
1Division of Pulmonary, Allergy, & Critical Care Medicine, Stanford University, Stanford, California, USA.
Lung pericytes are crucial for vascular health and disease. This review details their molecular mechanisms and roles in pulmonary conditions like ARDS and PAH.
Area of Science:
- Pulmonary vascular biology
- Cellular biology
- Molecular mechanisms
Background:
- Pericytes are mural cells vital for vascular homeostasis and repair in systemic circulation.
- Their role in lung vascular biology and disease pathogenesis is increasingly recognized but less understood.
- Growing evidence highlights lung pericyte involvement in vascular remodeling and inflammation.
Purpose of the Study:
- To comprehensively review current knowledge on lung pericyte function.
- To elucidate the molecular mechanisms governing lung pericyte biology.
- To explore the roles of lung pericytes in major pulmonary diseases.
Main Methods:
- Literature review synthesizing existing research on lung pericyte function.
- Focus on key signaling pathways (e.g., PDGF-BB/PDGFRβ, TGFβ, VEGF/VEGFR, Angiopoietin/Tie2, Notch, Wnt, S1P).
- Examination of downstream signaling cascades, including kinases, transcription factors, and mechanotransduction.
Main Results:
- Detailed analysis of signaling pathways controlling pericyte recruitment, proliferation, differentiation, and phenotypic plasticity.
- Identification of complex downstream signaling networks orchestrating pericyte behavior.
- Exploration of pericyte involvement in diverse pulmonary diseases.
Conclusions:
- Lung pericytes are active participants in pulmonary vascular remodeling and inflammatory responses.
- Understanding the molecular pathways governing lung pericyte function is critical for addressing pulmonary diseases.
- Further research into lung pericyte biology offers therapeutic potential for conditions like ALI/ARDS, fibrosis, PAH, lung cancer, and infections.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Regulation of Angiogenesis and Blood Supply
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
